Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

Eli Lilly plans to spend at least $27bn to build four new manufacturing plants in the United States, the drugmaker has said ...

Whatever you think of Donald Trump’s tariff policies, one fact stands out: companies are looking to invest more in the United ...

Eli Lilly (NYSE:LLY) announced plans to more than double its investments in domestic medicine production to over $50B on ...

Pharmaceutical giant expects the move will create 3,000 high-skilled jobs and provide work for approximately 10,000 ...

(Reuters) -Eli Lilly plans to spend at least $27 billion to build four ... The announcement comes less than a week after U.S.

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

Eli Lilly is doubling its U.S. manufacturing investment since 2020 as it seeks to produce more drugs domestically. Its latest ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs.

Eli Lilly plans to spend at least $27bn to build ... The announcement comes less than a week after US President Donald Trump met with chief executives from major drugmakers, including Lilly ...